Supercharging the future of healthcare with generative AI

It is estimated that by 2045, AI could support 50% of activities, with GenAI playing a significant role. As the evolution of older “discriminative” AI, it is poised to revolutionize healthcare.

Generative Artificial Intelligence (GenAI) and Large Language Models (LLMs) have been around for several years. Their widespread adoption has recently surged, causing a tidal wave of expectations. ChatGPT, for example, reached 100 million users within just three months.

GenAI: Unlocking Efficiency and Innovation in Healthcare

GenAI has the potential to transform the entire healthcare sector. But perhaps the first industry to benefit will be Life Sciences, especially drug research. In healthcare services, the shift towards GenAI and LLMs is gradual but expected to pick up speed. The insurance sector has been an early adopter of GenAI, enabling it to now reinvent and enhance its procedures.

Deploying these models requires careful attention to ethical and regulatory issues, including security, transparency, unbiased decision-making, and environmental impact. Systematic human oversight, especially in healthcare, is crucial.

The risk-based approach of the upcoming European AI Act is expected to be widely adopted soon, with particular scrutiny on GenAI for its most sensitive applications.

Download now:

By submitting this form, I understand that my data will be processed by Sogeti as described in the Privacy Policy.*